D-Index & Metrics Best Publications

Alexandros Makriyannis

Northeastern University
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Chemistry D-index 88 Citations 27,886 523 World Ranking 1309 National Ranking 551

Medicine D-index 90 Citations 26,927 462 World Ranking 7720 National Ranking 4161

Research.com Recognitions

Awards & Achievements

1993 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study Alexandros Makriyannis is best known for:

Enzyme
Endocannabinoid system
Cannabinoid receptor

While working on this project, Alexandros Makriyannis studies both Cannabinoid receptor and Cannabinoid receptor type 2. He incorporates Cannabinoid receptor type 2 and Endocannabinoid system in his research. With his scientific publications, his incorporates both Endocannabinoid system and Palmitoylethanolamide. Alexandros Makriyannis connects Palmitoylethanolamide with Fatty acid amide hydrolase in his research. Alexandros Makriyannis performs multidisciplinary studies into Fatty acid amide hydrolase and Cannabinoid in his work. He applies his multidisciplinary studies on Cannabinoid and AM251 in his research. In his papers, he integrates diverse fields, such as AM251 and Cannabinoid receptor. His Internalization research extends to Receptor, which is thematically connected. Much of his study explores Internalization relationship to Receptor.

His most cited work include:

Endocannabinoids control spasticity in a multiple sclerosis model (355 citations)
Structural determinants for recognition and translocation by the anandamide transporter (248 citations)
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (230 citations)

What are the main themes of his work throughout his whole career to date

With his scientific publications, his incorporates both Receptor and Enzyme. He combines Enzyme and Receptor in his studies. He undertakes interdisciplinary study in the fields of Cannabinoid receptor and Cannabinoid receptor antagonist through his research. He combines Cannabinoid receptor antagonist and Cannabinoid in his research. Alexandros Makriyannis undertakes interdisciplinary study in the fields of Cannabinoid and Cannabinoid receptor type 2 through his research. In his works, Alexandros Makriyannis conducts interdisciplinary research on Pharmacology and Neuroscience. He conducts interdisciplinary study in the fields of Neuroscience and Pharmacology through his research. He integrates Biochemistry with Cell biology in his research. Alexandros Makriyannis incorporates Cell biology and Biochemistry in his research.

Alexandros Makriyannis most often published in these fields:

Receptor (82.26%)
Cannabinoid receptor (79.03%)
Cannabinoid (70.97%)

What were the highlights of his more recent work (between 2011-2018)?

Cannabinoid receptor (87.50%)
Receptor (87.50%)
Biochemistry (62.50%)

In recent works Alexandros Makriyannis was focusing on the following fields of study:

His Cannabinoid Receptor Agonists research extends to Cannabinoid receptor, which is thematically connected. His research is interdisciplinary, bridging the disciplines of Cannabinoid receptor and Cannabinoid Receptor Agonists. His Receptor study frequently draws connections between adjacent fields such as Serotonin transporter. He performs integrative Serotonin transporter and Serotonin research in his work. Alexandros Makriyannis merges Serotonin with Endocannabinoid system in his research. In his works, Alexandros Makriyannis conducts interdisciplinary research on Endocannabinoid system and Diacylglycerol lipase. His Diacylglycerol lipase study frequently draws connections between related disciplines such as Biochemistry. His Biochemistry study often links to related topics such as Lipase. Alexandros Makriyannis performs multidisciplinary study in Lipase and Monoacylglycerol lipase in his work.

Between 2011 and 2018, his most popular works were:

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (230 citations)
Medicinal chemistry of cannabinoids (86 citations)
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice (46 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors

Marja D. Van Sickle;Marnie Duncan;Philip J. Kingsley;Abdeslam Mouihate.
Science (2005)

1742 Citations

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

M. Beltramo;N. Stella;N. Stella;N. Stella;A. Calignano;A. Calignano;A. Calignano;S. Y. Lin;S. Y. Lin;S. Y. Lin.
Science (1997)

1051 Citations

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

Mohab M. Ibrahim;Frank Porreca;Josephine Lai;Phillip J. Albrecht.
Proceedings of the National Academy of Sciences of the United States of America (2005)

623 Citations

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Mohab M. Ibrahim;Hongfeng Deng;Alexander Zvonok;Debra A. Cockayne.
Proceedings of the National Academy of Sciences of the United States of America (2003)

579 Citations

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.

Ruoxi Lan;Qian Liu;Pusheng Fan;Sonyuan Lin.
Journal of Medicinal Chemistry (1999)

563 Citations

CB2 cannabinoid receptor-mediated peripheral antinociception.

T.Philip Malan;Mohab M. Ibrahim;Hongfeng Deng;Qian Liu.
Pain (2001)

507 Citations

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Joseph Tam;V. Kiran Vemuri;Jie Liu;Sándor Bátkai.
Journal of Clinical Investigation (2010)

492 Citations

Endocannabinoids control spasticity in a multiple sclerosis model

D Baker;G Pryce;J L Croxford;P Brown.
The FASEB Journal (2001)

477 Citations

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

Ruth A Ross;Heather C Brockie;Lesley A Stevenson;Vicki L Murphy.
British Journal of Pharmacology (1999)

453 Citations

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

Sándor Bátkai;Zoltán Járai;Jens A. Wagner;Sravan K. Goparaju.
Nature Medicine (2001)

443 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Alexandros Makriyannis